QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study.
Eur Respir J
; 52(2)2018 08.
Article
in En
| MEDLINE
| ID: mdl-29880656
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Long QT Syndrome
/
Tuberculosis, Multidrug-Resistant
/
Antitubercular Agents
Type of study:
Clinical_trials
/
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Eur Respir J
Year:
2018
Type:
Article
Affiliation country:
France